- ►diabetesjournals.org MC Bunck, M Diamant, A Corner, B Eliasson, … - Diabetes Care, 2009 - Am Diabetes Assoc RESULTS Treatment-induced change in combined glucose- and arginine-stimulated
C-peptide secretion was 2.46-fold (95% CI 2.09–2.90, P < 0.0001) greater after
a 52-week exenatide treatment compared with insulin glargine treatment. ... Cited by 8 - Related articles - All 3 versions
T Mittendorf, J Smith-Palmer, L Timlin, M … - Diabetes, Obesity and Metabolism, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Related articles - All 4 versions
E Shahady - fafp.org Mr. A is a 55-year-old man who comes to your office for a “check up”. He is
a traveling salesman and has recently gained weight. He does not exercise much
and is a frequent visitor to fast food establishments. His father had a ... Related articles - View as HTML
V Faux - ssmg.be Le diabète de type 2 (non-insulinodépendant) résulte le plus souvent d'une
incapacité du pancréas endocrine à compenser une insulino- résistance
périphérique. Des études très récentes ont encore démontré ... Related articles - View as HTML
N Beeler, BM Riederer, G Waeber, A … - Brain Research Bulletin, 2009 - Elsevier Numerous epidemiological studies and some pharmacological clinical trials show
the close connection between Alzheimer disease (AD) and type 2 diabetes (T2D)
and thereby, shed more light into the existence of possible similar ... Cited by 1 - Related articles - All 2 versions
KPL Ligaray, WL Isley - phx1.medscape.com Type 2 diabetes mellitus is a group of disorders characterized by hyperglycemia
and associated with microvascular (ie, retinal, renal, possibly neuropathic),
macrovascular (ie, coronary, peripheral vascular), and neuropathic (ie, ... Related articles - Cached - All 4 versions
GE Peterson - jfponline.com According to the ADA/EASD consensus panel, 1 an overarching treatment principle
is to quickly attain glycemic control without causing hypoglycemia or weight
gain, and then maintain glycemic control over the patient's life span. ... Related articles - Cached - All 2 versions
N Helbecque, D Cottel, P Amouyel - Neurobiology of Aging, 2009 - Elsevier The sole known genetic risk factor for sporadic Alzheimer's disease (AD) is the
gene encoding apolipoprotein E (APOE), but the underlying mechanism is still
under debate. One hypothesis relies on an interaction between APOE and its ... Cited by 1 - Related articles - All 8 versions
SL Dennett, KS Boye, NR Yurgin - Value in Health, 2008 - ingentaconnect.com Various utility values associated with body weight using different methodologies
have been published. Careful consideration should be given to determine the most
appropriate utility values to use in CUAs of T2DM therapies. Cited by 3 - Related articles - BL Direct - All 2 versions
